8-KOther EventsExhibits & Filings

Edwards Lifesciences Corp 8-K Report, Corporate Update (May 1, 2018)

Filed May 1, 2018For Securities:EW

Summary

Edwards Lifesciences Corporation (EW) announced on May 1, 2018, its entry into an accelerated share repurchase (ASR) agreement. This agreement signifies a proactive capital allocation strategy by the company, indicating management's confidence in the company's financial health and future prospects. Investors should view this as a positive signal, as share repurchases can increase earnings per share (EPS) by reducing the number of outstanding shares. The ASR structure allows for a significant portion of the repurchase to occur rapidly, potentially providing an immediate boost to shareholder value. The press release detailing this event, filed as Exhibit 99.1, is the primary source of information regarding this significant corporate action.

Key Highlights

  • 1Edwards Lifesciences entered into an Accelerated Share Repurchase (ASR) agreement on April 30, 2018.
  • 2The company issued a press release on May 1, 2018, to announce this ASR agreement.
  • 3This ASR agreement is an 'Other Event' and is disclosed under Item 8.01 of the 8-K filing.
  • 4The ASR agreement suggests a commitment to returning capital to shareholders.
  • 5The Chief Financial Officer, Scott B. Ullem, signed off on the filing.
  • 6No new financial statements or material contracts were filed with this 8-K, beyond the press release.

Frequently Asked Questions

An Accelerated Share Repurchase (ASR) agreement is a contract where a company buys back a significant number of its own shares from an investment bank over a short period. It's a way for companies to quickly reduce the number of outstanding shares and return capital to shareholders.

Companies typically enter ASR agreements when they believe their stock is undervalued, they have excess cash flow, and management has confidence in the company's future performance. It can increase earnings per share (EPS) and signal confidence to the market.

While the exact dollar amount and number of shares to be repurchased are detailed in the press release (Exhibit 99.1), the general financial impact is a reduction in the company's cash on hand and a decrease in the number of outstanding shares. This can lead to an increase in earnings per share (EPS).

More specific details regarding the ASR agreement, including the amount of the repurchase, are available in the press release filed as Exhibit 99.1 to this 8-K filing.